The deoxyglucose technique for the measurement of local cerebral glucose metabolism (LCMRgi) has been widely applied in animals utilizing 14C-deoxyglucose and in humans employing 18F-fluorodeoxyglucose. Repeat studies in humans over a relatively brief period of time have not been possible because of the lID-min half-life of fluorine-IS. With the synthesis of ll C _ deoxyglucose it has now become possible to utilize this short-lived (20 min)
glucose metabolism in normal and altered states Sokoloff, 1981) . Recently it has been possible to extend this type of study to humans using 18F-2-deoxy-2-fluoro-D-glucose (1SF-FDG), as the tracer and positron emission to mography to quantitate the radioactivity concen tration in discrete volumes of brain tissue Reivich et al. , 1979) . Furthermore, the short half-life of fluorine-18 (110 min) allows the measurement of LCMRgl to be carried out safely in humans in a number of conditions, including normal physiological stimuli (Reivich et al., 1978; Green-berg et aI. , 1981; Phelps et aI. , 1981) , stroke (Kuhl et aI., 1980a) , seizures (Kuhl et aI. , 1980b) , brain tumors (Di Chiro et aI., 1981) , schizophrenia (Far kas et aI. , 1980) , and senile dementia (Ferris et aI. , 1980; Alavi et aI. , 1981) . In the majority of the studies with 18F-FDG, single determinations of glu cose consumption were made. In the few cases in which repeat determinations were made in the same individual (Ferris et aI., 1980; Kuhl et aI., 1980b) at least a day between studies was required for the decay of 18F to background levels. This required repeat vascular puncture for the administration of tracer and collection of blood samples.
Since a statistical advantage would result from making the control and experimental measurement of the same subject over a relatively short period of time, we have developed a method for labeling 2deoxy-o-glucose with carbon-II, a positron emitter with a 20. 4-min half-life (Shiue et aI., 1979; Mac Gregor et aI. , 1981) .
There are several distinct advantages to the llC deoxyglucose (llC-DG) technique. The most im portant of these is the demonstration of replication in a single individual, i.e., that the metabolic pat terns seen are distinct for that individual and are constant when all exterior conditions remain the same. In addition, repeat studies within a few hours of each other are possible because of the short half-life of carbon-II. In sensory stimulation studies or those involving drug intervention, inter-subject variability can be minimized since the subject can act as his own control. Finally, the radiation dose to the subject is somewhat lower than that encoun tered with 18FDG.
PLASMA CEREBRAL TISSUE
We report here the first studies in humans utiliz ing llC _ DG in serial studies in the same subject.
METHODS

Theory
The study of regional glucose metabolism in hu mans (Reivich et aI. , 1979) is based upon the 14C _ deoxyglucose autoradiographic technique for the determination of LCMRgl in animals (Sokoloff et ai. , 1977) . In the present work, llC-2-deoxy-o glucose is used as the tracer for glucose metabo lism. Based upon the model shown in Fig. 1 and several assumptions enumerated below, an opera tional equation can be developed that enables one to determine LCMRgl in terms of measurable param eters. This model considers that glucose and deoxyglucose share and compete for a common transport carrier between plasma and brain tissue. Once transported into a common homogeneous precursor pool, glucose and deoxyglucose either compete for a common carrier for transport back from brain to plasma, or for hexokinase for phos phorylation to their respective hexose-6-phosphates. In this model, it is assumed that deoxyglucose-6-phosphate (DG-6-P), once formed, is not further metabolized and is trapped in the tissues. This assumption, however, is not necessary and, as shown by Phelps et al. (1979) , the model can be extended to include the presence of phosphatase activity in the brain if required in a particular in stance. However, since phosphatase activity is in
Theoretical model for transport and metabolism of glucose and deoxy glucose in the brain. Cp and Co' represent the concentrations of glucose and "C_ deoxyglucose in the arterial plasma, re spectively; CE and C; represent their re spective concentrations in the tissue pools that serve as substrates for hexokinase; and CM and CM' represent the concentrations of glucose-6-phosphate and "C-deoxyglucose-6-phosphate in the tissue. The constants k�, k;, and k; repre sent the rate constants for carrier-me diated transport of "C-deoxyglucose from plasma to tissue, from tissue back to plasma, and for phosphorylation by hexokinase, respectively. The constants k" k2' ka are the equivalent rate constants for glucose.
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( C E *) very low concentrations in the brain, this term can be omitted for studies performed over a period of 50 min. In order to use this model to quantify the rate of local cerebral glucose utilization, the following as sumptions in addition to those above are required:
(1) the local region is homogeneous with respect to blood flow, rates of transport of glucose, and llC-DG between plasma and tissue, and rates of phosphorylation of glucose and llC-DG; (2) these rates and the plasma glucose concentration are con stant during the period of measurement; (3) the llC-DG and glucose are present in a single com partment in each homogeneous local region; (4) the IlC-DG and IlC-DG-6-P are present in trace amounts; and (5) the arterial plasma concentrations of glucose and IlC _ DG are approximately equal to their capillary plasma concentrations. Since the ce rebral extraction ratios of glucose and llC-DG are normally very low, approximately 10%, the mean capillary plasma concentrations are fairly well ap proximated by the arterial plasma concentrations. On the basis of this model and these assumptions, the folJowing operational equation can be derived:
Thus, by quantitating the total llC activity re gionally by means of positron emission tomogra phy, measuring the time course of arterial llC-DG specific activity, and knowing the values of kl, k�, k�, and the LC for llC-DG in man, it is possible to calculate the LCMRgl in various structures of the brain.
In these studies, the regional llC activities were determined with the PETT III (Ter-Pogossian et aI. , 1975) scanner at Brookhaven National Laboratory. This scanner consists of 48 NaI (Tl) scintillation detectors in a hexagonal array. Each side of the hexagon has eight detectors mounted on a platform capable of rectilinear motion and the entire hexagon is mounted on a gantry capable of rotating. Colli mation is achieved by measuring only positron annihilation radiation, by having each detector in coincidence with alJ the detectors in the opposite bank. With translation of the banks (1 cm) and rota tion of the gantry (60 degrees in 3-degree incre ments), the radioactivity in the brain tissue is mea sured from a number of angles. From the measured data, transverse sections through the brain were calculated using a filtered, back-projection recon-
where R is the calculated rate of glucose consump tion per gram of tissue; Cf is the concentration of DG + DG-6-P in the tissue; ct and Cp are the arte rial plasma concentrations of DG and glucose, re spectively; k*t, k�, and k� are the rate constants for the transport from plasma to the tissue precursor pool, for the transport back from tissue to plasma, and for the phosphorylation of DG in the tissue, respectively; " is the ratio of the distribution vol ume of DG in the tissue to that of glucose; 4> is the fraction of glucose that, once phosphorylated, con tinues down the glycolytic pathway; and K � and V�ax and Km and V max are the kinetic constants of hexokinase for DG and glucose, respectively. The latter six constants can be combined into one con stant, which has been designated the lumped con stant (" . V�ax' Kml4>' V max' K�) (LC). struction technique (Herman, 1980) . The intrinsic spatial resolution of the PETT III in the plane of the section is 1.7 cm full-width-half-maximum. In addition to the determination of the distribu tion of brain llC-activity, knowledge of both the arterial blood plasma glucose and llC-DG concen trations as a function of time folJowing the intrave nous administration of llC _ DG is required. In order to minimize the amount of free llC in the precursor pool, the !1C-DG is administered as a bolus and then 30 min are allowed to elapse before the brain dis tribution of !1C activity is determined. Thus, most of the llC activity in the section scan is in the form of llC-DG-6-P. Correction is made for the small amount of free !1C-DG present from knowledge of the arterial plasma llC _ DG time course and the turn over rate of the precursor pool.
Preparation of llC-2-DeoxY-D-glucose llC-2-DeoxY-D-glucose was prepared at Brook haven National Laboratory as described previously (MacGregor et aI. , 1981) . The radiochemical purity was 97-99% as determined by thin layer chro matography (MacGregor et aI. , 1981) and the spe cific activity (at time of injection) was 14-45 mCi/mg. Pharmaceutical quality llC _ DG in isotonic saline for use in the human studies was sterilized by terminal Millipore (0.22 jLm) filtration. The prepa ration was carried out according to a protocol that was demonstrated on three successive runs to yield a sterile pyrogen-free product.! For the human studies reported herein, up to four preparations of The samples were immediately centrifuged and the plasma separated and counted in a well counter along with 68Ga standards, which had previously been counted on the scanner, to enable the blood and tissue activity to be expressed in the equivalent units.
Determination of k Values
It can be demonstrated (Sokoloff et aI., 1977) that the rate constants are mathematically related to the time course of the total concentration of llC activity in a tissue and the time course of the arterial plasma llC-DG concentration by the following equation:
Jo llC-DG were made per day, allowing two serial studies on two subjects.
LCMRgI Determination
The determination of LCMRgl was carried out in a series of nine normal male subjects aged 19 to 26 years. Percutaneous radial artery catheterization was performed using a 20-gauge, 2-inch (5.1 cm) catheter and the brachial vein was punctured with a 20-gauge needle. The arterial line was kept open by means of a pressurized drip system and the venous line by means of an i.v. infusion. The subject was then made comfortable in the PETT III scanner. The subjects had their eyes open and ears plugged. Conversation in the room was kept to a minimum and conducted in low tones when absolutely neces sary. Approximately 30 min after the radial artery and brachial vein catheterizations were performed, a baseline arterial sample was drawn for llC-DG, glucose, and blood gases. An i.v. bolus injection of 3.5-11.3 mCi of llC-DG was then administered. Arterial blood samples were obtained initially every 15 s for 1 min and then every minute for 9 min and finally every 5 min for 50 min, for a total sampling period of 60 min.
1 Tests for sterility and apyrogenicity were performed by Liuzzi Microbiology Laboratory, 272 Islip Avenue, Islip, New York 11751. 1982 where Ct(T) equals the tissue llC activity at time T. The other terms are as defined above.
Thus, by determining the tissue and arterial plasma concentrations of l1C as a function of time following the intravenous administration of a bolus of llC-DG, it is possible to determine the values of q, k�, and k� using an iterative least-squares fitting technique. The arterial plasma llC concentration is obtained as described above while the tissue llC concentration time course was obtained by making section scans every 3 min for 30 min and then at 38 and 52 min after llC-DG administration. From the scans, the time course of llC activity in gray matter and white matter structures was determined. Using Eq. 2 and these arterial and tissue time course data, a best fit of values for k�, k�, and k� for various gray and white matter structures was determined. This was done as follows. The plasma data were first fitted to an empirical exponential expression relat ing Ct to time. The parameters of this expression were calculated using the function minimization procedure of Fletcher and Powell (1963) . This ex plicit expression was then used to represent ct in Eq. 2. The integration method of Gear (1971) was used to solve this differential equation, with the Fletcher-Powell minimization procedure selecting the best-fit rate constant values. Calculations were performed on a VAX 11/780 computer.
Determination of LCMRgl Reproducibility
Eight subjects were studied on two separate oc casions 120 min apart. Thirty minutes after the in jection of l1C-DG, scanning for the determination of LCMRgl was initiated. One to two scans were ob tained on each subject at +4 cm and + 5 cm above the orbitalmeatal plane. Each scan required 10 to 20 min to obtain and resulted in 500,000 to 1,500,000 counts in each image. Following this initial determi nation of LCMRgI, the subject was allowed to get up, void, and relax out of the scanner. Two hours after the first injection, the second determination of LCMRgl was initiated following the same procedure as above.
In one additional subject, two determinations of LCMRgl were performed 120 min apart. In the first study, the subject's eyes were closed and his ears were plugged, while during the second study the subject's eyes were opened and his ears remained plugged. The determinations of LCMRgl were per formed in an identical manner to that described above.
Determination of Radiation Dosimetry
Radiation dosimetry for the human use of HC-2DG was based on biodistribution measurements in dogs made with l1C-DG (Christman, 1981) , except for the brain and bladder wall. Human biodistribu tion data for 18F-FDG were used to estimate radia tion dose for the brain and the bladder wall, which receives the highest dose. These human data give a more realistic estimate of the radiation dose to the bladder wall because bladder time-activity curves were available.
Human data were collected during 10 18F-FDG studies in order to calculate the actual radiation dose to the bladder wall. The bladder time course Time after injection (min) was determined in these 10 subjects from injection time to 120 min after injection. The subject's total urine was collected and counted to determine the percent of injected dose in the bladder at this time. The 18F curves were corrected for 18F decay and then corrected to include HC decay (Fig. 2) . These l1C curves were then used to calculate the radiation dose for l1C-DG to the bladder wall. The contribu tion of urine accumulation after 2 h was measured in two subjects and results in a 10% increase in radia tion dose for 18F-FDG and a 2% increase for HC-DG.
The formula used to calculate the cumulated ac tivity, A (JLCi-h), for an injected dose of 1,000 JLCi was
where R is area under the bladder curve with HC decay included (cpm-h), H is the height of the blad der time course at void time (120 min) with l1C decay included (cpm), and U is the percent of in jected dose in the bladder at void time (120 min) with llC decay included (%). The "S" tables (Snyder et aI. , 1975) were then used to calculate the dose to the bladder wall for each of the 10 subjects from the activities in the bladder contents and the total body. The absorbed radiation dose for other organs from the injection of HC-DG was calculated using the dog tissue distributions at 30 min reported by Christman (1981) for HC from l1C-DG. It was as sumed that after an i. v. injection of 1 mCi of l1C-DG the organs instantaneously and uniformly take up the specified amounts of activity and the remainder (0.63 mCi) is instantaneously and uniformly distrib uted throughout the whole body, and that the effec tive clearance half time is 20.4 min (t 1 /2 of HC) for all 100 120
FIG. 2. The bladder probe time course collected for 2 h after 1sF-2FDG adminis tration for a typical subject is labeled "F-18 decay." The 1sF curve, corrected for 1sF decay, is labeled "No Decay." The "No Decay" curve, with the decay rate of "C included, is shown as the "C-11 Decay" curve. The cumulated activity for the bladder contents after "C-2DG adminis tration can be calculated from the area under the "C curve, the height of the curve at 2 h, and the total urine activity at 2 h.
organs. The estimated radiation doses to organs and whole body except for the heart and brain were cal culated according to the "s" tables. Absorbed fractions from MIRD Pamphlet No. 5 were used to calculate the doses to the heart and brain (Snyder et aI., 1969) . Additionally, it was assumed that there are no radioactive or radiochemical impurities in the l1C-DG.
RESULTS
K Values
Typical arterial and tissue curves for gray and white matter of l1C activity are shown in Fig. 3 . The mean values of q, kt and k� in nine subjects cal culated from these data are shown in Table 1 . AL though a number of distinct gray matter structures were examined separately, the results were not sig nificantly different from one another and so all gray matter structures were combined. Similary, the k* values of various white matter structures were not significantly different and their values were there fore combined. the striking reproducibility of LCMRgi. In Table 2 are the mean values for LCMRgl for Run 1 and Run 2 in various gray and white matter structures. Since the value of the LC for l1C-DG in man has not yet been determined, these values are expressed in mil ligrams per 100 grams per minute x LC. Also shown in the table are the percent differences between these values, defined as [(Run 1 -Run 2)/Run 1] x 100. This value is independent of the value of the LC, which appears in both the numerator and the de nominator as a factor. The coefficient of variation of the difference for repeat determinations is also shown for each structure. When the value for the LC for lIC-deoxyglucose in man has been deter mined, the values in this table can be divided by this value to provide LCMRgl values in terms of milli grams per 100 grams per minute. It would have been possible to calculate a value for the LC for l1C-DG in man, as has been done for 18F-FDG (Phelps et aI., 1979) , by using an average value for whole brain glucose consumption from the literature along with the measured values of k*1 , q, kt, and plasma arte rial glucose concentration. However, the values of LCMRgl thus obtained would have to be revised when a measured value of the lumped constant is available.
LCMRgl Values
The values of LCMRgl in the same units used in Table 2 are shown in Table 3 for the subject who 
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The curves have been decay- FIG. 4. Tomographic scan images from a control subject at two levels through the brain (+3 and +4 cm above the or bital� meatal (OM) plane). On the left are the scan images obtained following the first injection of "C-2-deoxyglucose, while the images on the right are scans on the same subject at the same levels following an injection of "C-2DG made 2 h later. The calculated metabolic rate ratios between the first and second study were frontal pole (FP) = 1.08; auditory cortex (AC) = 1.06; thalamus (TH) = 1.02; striate cortex (SC) = 1.06; visual association cortex (VA) = 1.09; frontal white (FW) = 1.05. The scan images were obtained in 10 min with between 1 and 1.5 million counts in each image. 
a Standard deviation of the difference between repeat measurements expressed as a percentage of the mean value of the metabolic rate for the structure.
" Standard deviation of all measurements divided by the mean metabolic rate. LC is lumped constant; number of subjects in parentheses.
was studied with eyes closed and eyes opened. Fig  ure 5 shows two section scans through the visual cortex in this subject, one with eyes open and the other with eyes closed. There was a significant in- Table 2 ) from the control value for this subject. (The probability that these increases are within normal vari ability is less than 0.01.)
,. Percentage change greater than 5 standard deviations (based on the normal values from Table 2) from the control value for this subject. (The probability that these increases are within normal vari ability is less than 0.001.)
J Cereb Blood Flow Metabol, Vol. 2, No.3, 1982 crease in glucose consumption with the eyes opened compared to eyes closed in the striate cortex and visual association areas. These changes were 52% and 36%, respectively. The probability that these increases are within normal variability is less than 0.01. In all other regions, the difference was no greater than 23%. The changes in the frontal white matter and corpus callosum were borderline signifi cant.
Radiation Dosimetry
The calculated radiation dose to the bladder wall in 10 subjects is presented in Table 4 . The mean radiation dose to the bladder wall (±SE) was 133 ± 25 mrad/mCi for l1C-DG, with a range from 56.4 to 305 mrad/mCi. The variability in radiation dose between subjects is caused by the difference in the percent of the injected activity that was excreted into the bladder. Table 5 presents the calculated radiation doses to all organs. The critical organ is the bladder wall, which receives a mean radiation dose of 133 mradl mCi. For a 15-mCi injection of l1C-2DG, the bladder wall receives 2 rads.
OM+4 OM+6
FIG. 5. Tomographic scan images at two different levels (top, +4 cm above the orbital-meatal (OM) plane; bottom, +6 cm above the OM plane) of a subject whose cerebral metabolic rate for glucose has been measured twice, 2 h apart. On the left are images obtained with the subject not receiving any visual stimulation (closed eyes). On the right are images obtained during visual stimulation consisting of colorful pictures presented to his central visual field. The regional glucose utilization rates are in Table  3 . The scan times were 10 min with 1-1.5 million counts in each image.
DISCUSSION
Feasibility of Human Studies at Short
Time Intervals
Because of the short half-life of carbon-ll, the use of l1C-DG in human subjects must be carried out at an accelerator-PETT center where the facilities and expertise for radio nuclide production and rapid organic synthesis exist. Although the synthesis of l1C-2DG is comprised of a number of steps, the experimental set-up is sufficiently simple that it is readily carried out at 2-h intervals, and the studies reported herein were typically carried out at a rate of four per day (two subjects each having two l1C-DG PETT scans).
Kinetic Rate Constants
Mean gray and white matter values of the kinetic rate constants are reported since values for indi vidual gray or white matter structures were not sig nificantly different, due to the large individual vari ation among subjects.
The kinetic rate constants for DG have not been measured previously in humans. There are data for DG in rats and monkeys, however, with which these values can be compared as well as data for " Based on 1-mCi injection and dog biodistributions reported by Christman (1981) , except for brain and bladder wall.
o Estimate based on relative weight; assume 1.5% of dose to red marrow.
(' Calculated using absorbed fractions from MIRD Pamphlet No. 5 (Snyder et aI., 1969) .
d Based on human biodistribution measurements of lRF-2FDG.
FDG in humans (Table 1) . Our values for q and k� for DG in humans for gray and white matter are somewhat lower than those determined in the rat by Sokoloff et al. (1977) , whereas our values for k"3 are higher. These differences may be due to species differences. On the other hand, the values of the kinetic rate constants for DG and FDG in humans are very similar, suggesting that these two analogues of glucose have similar affinities for the facilitated transport system and are similar as sub strates for hexokinase in the brain. Phosphatase activity in mammalian brain is low (Hers and DeDuve, 1950; Hers, 1957; Raggi et al., 1960; Prasannan and Subrahmanyan, 1968) . A negligible error is produced by not including phos phatase activity in the model, i.e., by omitting kt the kinetic rate constant for phosphatase activity. An estimate of this error can be made assuming that k� for DG is similar to that for FDG, since the val ues for k'l, k�, and k"3 are similar. Using these values of k�, 0.0055 and 0.0041 for gray and white matter, respectively (Reivich et al., unpublished observa tions) and the model including k�, the values of LCMRgl were recalculated. The difference varied from 6% at 35 min to a maximum of 11% at 55 min post-injection in gray matter. The corresponding values for white matter were 3% and 6%. Further more, if values of k'l to k� were simultaneously evaluated from tissue and plasma time course data, these errors would be smaller. Practically, it would J Cereb Blood Flow Metabol, Vol. 2, No. 3, 1982 be difficult to measure k�, since this would require making scans at 100-200 min after l1C-DG admin istration. Little activity would be present in the brain at that time (less than 10 nCi/g, which yields approximately 5,000 counts/slice/minute), resulting in a very large statistical error.
Precursor Pool Turnover
The fractional turnover rate of the precursor pool is approximated by (k� + k"3) when k� is small. Under these conditions, the half-life of the precur sor pool is equal to In 2/(k� + k"3). The half-life of the white matter pool is significantly higher than that of the gray matter pool. Both values agree fairly well with those for DG in white and gray matter in the rat and monkey. They are both appreciably lower than the values reported for FDG in humans. This may be due to chemical differences between DG and FDG. Table 6 shows the calculated concentrations of DG and DG-6-P, expressed as a percentage of total tissue activity as a function of time. These values are in good agreement with those of Sokoloff et al. (1977) for DG in the rat and of Phelps et al. (1979) for FDG in humans. They do not agree well with the data of Hawkins and Miller (1978) for DG in the rat. The latter authors report that at 10 min, net phos- phorylation of DG ceases, even though significant amounts of DG are present in the blood and tissue. As pointed out by Phelps et al. (1979) , this is proba bly due to the fact that Hawkins and Miller (1978) underestimated the early portion of the plasma DG curve by representing it with a single exponential. This had the effect of significantly overestimating the relative amount of DG supplied to the tissue at later times and thus caused an overestimation of the rate of dephosphorylation. The rate of DG-6-P for mation is slower in our human data compared to the rat, as would be expected since LCMRgl is lower in humans.
Distribution of DG and DG-6-P in Tissues
The distribution volume or partition coefficient for DG between the tissue and plasma is approxi mated by kV(kt. + k'5) when k� is small. These values for DG in humans are smaller than those re ported by Sokoloff et al. (1977) in rats and for FDG in humans reported by Phelps et al. (1979) . These dif ferences may be due to species and chemical differ ences, respectively. Since glucose is transported into the brain by a saturable facilitated transport mechanism and not by active transport (Buschiazzo et aI., 1970; Culter and Sipe, 1971; Yudilevich and DeRose, 1971; Betz et aI., 1973; Fishman, 1973) , the plasma concentration of glucose would be expected to be higher than that of the tissue, and thus the distribution volumes would be expected to be less than one.
Assuming an average local cerebral volume of 3.1% due to small vessels in the tissue (Phelps et aI., 1979) , the ratio of distribution volumes of 2deoxyglucose in the blood and the tissue can be calculated. Both plasma deoxyglucose and brain tissue deoxyglucose are measured directly in our subjects, from blood samples and tomographic measurements, respectively. Thirty minutes after the administration of the l1C-DG, 1.6% of the mea sured activity originates from the plasma. Correct ing for cerebral hematocrit and the relative dis tribution of DG in the red blood cells and plasma (assumed similar to that of FDG) (Phelps et aI., 1979) the percent of activity in the whole blood of the tissue becomes 2.3%. Since at 30 min 17.6% of the tissue counts originate from free unmetabolized DG, the relative distribution volume of DG between blood and tissue is 0.25. This agrees with the value of 0.29 for whole brain determined from the k* values (Table O .
LCMRgI Values
Although the assumption of a homogeneous met abolic rate for glucose in each region of measure ment is not valid when using a positron tomographic scanner with a resolution of 1. 7-cm full-width half-maximum, due to the linearity of the model, within the gray (white) matter the metabolic rate as measured from the tissue concentration is simply the average metabolic rate of the tissue region being imaged. The relative insensitivity of the DG model to the moderate differences in the k* values be tween gray and white matter minimizes the error in using the average tissue concentration of radioiso tope to calculate the average metabolic rate of glu cose in resolution elements containing both gray and white matter.
Since the value of the LC for DG in the human is not known and remains to be determined, the values for LCMRgI reported in this paper have been cal culated with the value of LC set equal to one. When this information becomes available, the values in Table 2 need only be divided by the value of the LC to yield the appropriate values for LCMRgl. We prefer to present the data in this form rather than use an assumed or calculated value for the LC. The ratio of gray to white matter values for LCMRgI is approximately 1.3, rather than the expected value of 3.0 or 4.0. This is due to the rather limited reso lution of the PETT III tomographic scanner (1.7-cm full-width-half-maximum intrinsic resolution) which, due to the partial volume effect, will under estimate the tissue concentration of llC in the gray matter and overestimate this concentration in white matter. The metabolic rates listed in Table 2 are appreciably underestimated due to the relationship between the size of the structure and the resolution of the PETT III tomographic scanner. The values tabulated are approximately 50% of the actual values (Mazziotta et aI. , 1981) .
The main advantage of llC-DG over 18F-FDG is the ability to repeat a measurement in the same subject within a relatively short period of time, 2 h (i. e. , six half-lives), with essentially no activity present from the first measurement. With 18F-FDG this would require an 11-h period or, essentially, the next day before a repeat study could be done under similar conditions. The ability for a subject to thus act as his own control reduces the variability be tween measurements and increases the power of the method to detect small changes in metabolism. The precision of the technique, as measured by the coefficient of variation of repeated measurements 2 h apart, was 5. 2% to 8.7% for various gray matter structures and 9.7% to 14.0% for white matter structures. Therefore, a change of approximately 15% in gray matter and 23% in white matter in a given subject could be considered to be significant, whereas these values would be 22% for both gray and white matter if the subject did not act as his own control. Smaller changes in left/right ratios can be detected (Table 7) ; however, this can lead to am biguity since we are never sure that bilateral changes have not occurred.
Radiation Dosimetry
The radiation exposure is approximately the same using IlC-DG as it is with 18F _ FDG (Reivich et aI., 1979) . Although the dose per millicurie is less to the various organs (Table 5) , approximately three times the amount of 11C must be injected, because of its shorter half-life, to achieve comparable counts in the section scans. Thus, the dose per study with llC is approximately 90% that of the dose when 18F _ FDG is used. The radiation dose to the bladder wall can be re duced by maintaining a moderately full bladder be fore injection of IIC _ DG and voiding as soon as possible after the study.
The radiation dose for the bladder wall in Table 5 is lower than the radiation dose calculated from dog tissue distributions from llC-DG (Christman, 1981) . The bladder wall dose estimated from the dog data was 270 mrad/mCi, compared with the result pre sented here of 133 mrad/mCi. The result from this work is lower because human bladder time-activity curves, acquired using 18F-FDG, were used to cal culate the radiation dose.
In conclusion, the first studies in humans utilizing IIC-DG in serial measurements in the same subject are presented. Repeated studies within a few hours of each other are now possible because of the short half-life of IIC. This work has demonstrated that the pattern of cerebral metabolic rates is relatively con stant in a given individual when the conditions of the study remain the same. The ability to make repeat measurements in the same subject allows the subject to act as his own control and thus minimizes inter-subject variability, allowing smaller changes in regional cerebral glucose metabolism to be detected with confidence.
